Company / EPS (Diluted)
Seres Therapeutics, Inc. EPS (Diluted) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$17.77
FY2025
5-year range
-$17.77 / -$0.72
FY2021-FY2025
Trend
-2368.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -2368% YoY in FY2025, a notable deviation from the 9-year average annual change of -268%.
Based on SEC 10-K filings.
-17.77 in FY2025.
Declined from $-1.12 to $-17.77 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 2368.1% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$17.77 | -2368.1% |
| FY2023 | -$0.72 | +35.7% |
| FY2022 | -$1.12 | +9.7% |
| FY2021 | -$1.24 | +49.0% |
| FY2020 | -$2.43 | -10.0% |
| FY2019 | -$2.21 | +3.9% |
| FY2018 | -$2.30 | +1.3% |
| FY2017 | -$2.33 | +12.7% |
| FY2016 | -$2.67 | -145.0% |
| FY2015 | -$1.09 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026